BioSpace News Archive

Pharm Country

Cyclacel Pharmaceuticals Reviews 2021 Achievements And Announces Key Business Objectives for 2022

Cyclacel Pharmaceuticals, Inc. today provided a business update reviewing 2021 achievements and outlining the Company’s key business objectives for 2022.

January 6, 2022
·
5 min read
Deals

CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

CNS Pharmaceuticals, Inc. announced today that it has entered into securities purchase agreements with several institutional and accredited investors.

January 6, 2022
·
5 min read
Business

CENTENE APPOINTS JIM MURRAY AS CHIEF TRANSFORMATION OFFICER

Centene Corporation (NYSE: CNC) today announced that Jim Murray has been appointed as Chief Transformation Officer.

January 6, 2022
·
9 min read
Drug Development

Curis Announces Updated Data with Additional Encouraging Clinical Activity in Phase 1/2 Study of CA-4948 Monotherapy

Curis, Inc. today announced positive updated clinical data from the ongoing open label Phase 1/2 dose escalation and expansion study of CA-4948.

January 6, 2022
·
15 min read
Business

Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin

Optimvia and Ginkgo Bioworks today announced a partnership to improve the manufacturing efficiency of biosynthetic heparin.

January 6, 2022
·
5 min read
Biotech Bay

Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

Sutro Biopharma, Inc. today announced that Bill Newell, Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, Jan. 13, 2022, at 11:15 a.m. ET / 8:15 a.m. PT.

January 6, 2022
·
3 min read
Synairgen announces global strategic partnership with Ashfield Engage

Synairgen plc, the respiratory company developing SNG001 for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs, announces a partnership with global experts in strategic engagement and commercialisation, Ashfield Engage.

January 6, 2022
·
4 min read
Deals

Odyssey Therapeutics Acquires Rahko, a Quantum Machine Learning Company

Odyssey Therapeutics announced that it has acquired Rahko, a leading quantum machine learning company, adding powerful new tools to Odyssey’s discovery platform to enable faster and more efficient drug discovery.

January 6, 2022
·
3 min read
Genetown

Marengo Therapeutics to Present at Annual J.P. Morgan Health Care Conference

Marengo Therapeutics, Inc. today announced that Zhen Su , M.D., MBA, Chief Executive Officer of Marengo Therapeutics, will present at the 40th Annual J.P. Morgan Health Care Conference.

January 6, 2022
·
1 min read
Biotech Bay

Antiva Biosciences Named Winner of Global Women’s HealthTech Award By World Bank Group and Consumer Technology Association

Honor Recognizes Companies Advancing Innovative Solutions to Improve Women’s Health and Safety in Emerging Markets.

January 6, 2022
·
3 min read